Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature Medicine 15, 696 - 700 (2009)
Published online: 31 May 2009 | doi:10.1038/nm.1973
Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon–dependent exhaustion
Taku Sato1,2, Nobuyuki Onai1,2, Hiroki Yoshihara3, Fumio Arai3, Toshio Suda3 & Toshiaki Ohteki1,2,4
Abstract
Type I interferons (IFNs), a family of cytokines, orchestrate numerous biological and cellular processes1, 2, 3. Although it is well known that type I IFNs are essential for establishing the host antiviral state4, their role in hematopoietic homeostasis has not been studied. Here we show that type I IFNs induce proliferation and exhaustion in hematopoietic stem cells (HSCs) and that interferon regulatory factor-2 (IRF2), a transcriptional suppressor of type I IFN signaling5, 6, preserves the self-renewal and multilineage differentiation capacity of HSCs. HSCs were substantially less abundant in the bone marrow of Irf2-/- as compared to Irf2+/- mice. Irf2-/- HSCs showed enhanced cell cycling status and failed to produce hematopoietic cells in competitive repopulation assays, and the reconstituting capacity of Irf2-/- HSCs was restored by disabling type I IFN signaling in these cells. In wild-type mice, injection of poly(I:C), an inducer of type I IFN signaling, or IFN-
induced HSC proliferation, and chronic type I IFN signaling further reduced the number of quiescent HSCs. Notably, combined poly(I:C) and 5-fluorouracil (5-FU) treatment allowed exogenous HSC engraftment and hematopoietic reconstitution in WT mice. Our findings provide insight into the molecular basis for the maintenance of HSC quiescence and may lead to improvements in bone marrow transplantation and type I IFN–based therapies for viral infection and cancer.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Abolition of specific immune response defect by immunization with dendritic cellsNature Letters to Editor (07 Nov 1985)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature Letters to Editor (14 Apr 2005)
An olivine-free mantle source of Hawaiian shield basaltsNature Article (31 Mar 2005)
Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activationNature Immunology Article (01 Oct 2006)
See all 70 matches for Research